Millipore Sigma Vibrant Logo

504535 QNZ46 - CAS 1237744-13-6 - Calbiochem

QNZ46 - CAS 1237744-13-6 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: NMDA Antagonist VIII, 4-[6-Methoxy-2-[(1E)-2-(3-nitrophenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl]-Benzoic acid

Primary Target: NMDA receptors
View Products on Sigmaaldrich.com
504535
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

CAS #Empirical Formula
1237744-13-6C₂₄H₁₇N₃O₆

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
5.04535.0001
Retrieving availability...
—
Fulfilment and delivery delayed Fulfilment and delivery delayed
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Glass bottle 5 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewA noncompetitive and voltage-independent antagonist selective for NR2C/D containing NMDA receptors (IC50 = 6, 3, 229, and >300 µM for NR2C, NR2D, NR2A, and NR2B, respectively). Inhibition on NR2C/D containing NMDA receptors is glutamate-binding, but not glycine-binding, dependent. Represents a new class of noncompetitive subunit-selective NMDA receptor antagonists. With more than 100-fold selectivity for recombinant NMDA receptors over AMPA and kainate receptors.
      Catalogue Number504535
      Brand Family Calbiochem®
      SynonymsNMDA Antagonist VIII, 4-[6-Methoxy-2-[(1E)-2-(3-nitrophenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl]-Benzoic acid
      References
      ReferencesMayer, M., et al. 2013. Annu. Rev. Physiol. 75, 1.
      Hansen, K., 2011. J. Neurosci. 9, 3650.
      Mosley, C., et al. 2010. J. Med. Chem. 53, 5476.
      Product Information
      CAS number1237744-13-6
      FormYellow powder
      Hill FormulaC₂₄H₁₇N₃O₆
      Chemical formulaC₂₄H₁₇N₃O₆
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetNMDA receptors
      Primary Target IC<sub>50</sub>6, 3, 229, and >300 →M for NR2C, NR2D, NR2A, and NR2B, respectively.
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      QNZ46 - CAS 1237744-13-6 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      References

      Reference overview
      Mayer, M., et al. 2013. Annu. Rev. Physiol. 75, 1.
      Hansen, K., 2011. J. Neurosci. 9, 3650.
      Mosley, C., et al. 2010. J. Med. Chem. 53, 5476.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision28-June-2013 JSW
      SynonymsNMDA Antagonist VIII, 4-[6-Methoxy-2-[(1E)-2-(3-nitrophenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl]-Benzoic acid
      DescriptionA noncompetitive and voltage-independent antagonist selective for NR2C/D containing NMDA receptors (IC50 = 6, 3, 229, and >300 µM for NR2C, NR2D, NR2A, and NR2B, respectively). Inhibition on NR2C/D containing NMDA receptors is glutamate-binding, but not glycine-binding, dependent. Represents a new class of noncompetitive subunit-selective NMDA receptor antagonists. With more than 100-fold selectivity for recombinant NMDA receptors over AMPA and kainate receptors.
      FormYellow powder
      CAS number1237744-13-6
      Chemical formulaC₂₄H₁₇N₃O₆
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (5 mg/ml). Slight warming is required for complete solubilization.
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesMayer, M., et al. 2013. Annu. Rev. Physiol. 75, 1.
      Hansen, K., 2011. J. Neurosci. 9, 3650.
      Mosley, C., et al. 2010. J. Med. Chem. 53, 5476.